DE69918671D1 - Optische papillarzirkulation verbesserende mittel - Google Patents

Optische papillarzirkulation verbesserende mittel

Info

Publication number
DE69918671D1
DE69918671D1 DE69918671T DE69918671T DE69918671D1 DE 69918671 D1 DE69918671 D1 DE 69918671D1 DE 69918671 T DE69918671 T DE 69918671T DE 69918671 T DE69918671 T DE 69918671T DE 69918671 D1 DE69918671 D1 DE 69918671D1
Authority
DE
Germany
Prior art keywords
optic nerve
nerve head
papillar
optical
circulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69918671T
Other languages
English (en)
Other versions
DE69918671T2 (de
Inventor
Hideaki Hara
Masamitsu Shimazawa
Yasushi Iwakura
Tetsuya Sugiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE69918671D1 publication Critical patent/DE69918671D1/de
Publication of DE69918671T2 publication Critical patent/DE69918671T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE69918671T 1998-01-29 1999-01-21 Optische papillarzirkulation verbessernde mittel Expired - Fee Related DE69918671T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP1683198 1998-01-29
JP1683198 1998-01-29
JP25237598 1998-09-07
JP25237598 1998-09-07
PCT/JP1999/000202 WO1999038515A1 (fr) 1998-01-29 1999-01-21 Agents ameliorant la circulation optique papillaire

Publications (2)

Publication Number Publication Date
DE69918671D1 true DE69918671D1 (de) 2004-08-19
DE69918671T2 DE69918671T2 (de) 2005-07-28

Family

ID=26353257

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69918671T Expired - Fee Related DE69918671T2 (de) 1998-01-29 1999-01-21 Optische papillarzirkulation verbessernde mittel

Country Status (11)

Country Link
US (1) US6387910B1 (de)
EP (1) EP1051973B1 (de)
JP (1) JP4456269B2 (de)
KR (1) KR100585299B1 (de)
CN (1) CN1149086C (de)
AT (1) ATE270890T1 (de)
DE (1) DE69918671T2 (de)
ES (1) ES2224597T3 (de)
PT (1) PT1051973E (de)
TW (1) TW461815B (de)
WO (1) WO1999038515A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9365553B2 (en) * 2010-05-27 2016-06-14 Aska Pharmaceutical Co., Ltd. Heterocyclic compound and H1 receptor antagonist
CN109580836A (zh) * 2018-12-31 2019-04-05 辰欣药业股份有限公司 一种盐酸洛美利嗪原料及制剂有关物质的检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60222472A (ja) 1984-03-30 1985-11-07 Kanebo Ltd 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物
AU4807790A (en) 1988-12-05 1990-06-26 Houston Biotechnology Incorporated Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction
FR2669132A1 (fr) * 1990-11-09 1992-05-15 Guerin James Dispositif de memorisation d'informations connectable a un ordinateur.
CA2131101A1 (en) * 1992-05-13 1993-11-25 Louis Desantis Jr. Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents

Also Published As

Publication number Publication date
DE69918671T2 (de) 2005-07-28
KR100585299B1 (ko) 2006-06-01
PT1051973E (pt) 2004-11-30
TW461815B (en) 2001-11-01
KR20010024889A (ko) 2001-03-26
US6387910B1 (en) 2002-05-14
CN1295475A (zh) 2001-05-16
EP1051973A4 (de) 2002-02-06
EP1051973A1 (de) 2000-11-15
ES2224597T3 (es) 2005-03-01
ATE270890T1 (de) 2004-07-15
WO1999038515A1 (fr) 1999-08-05
EP1051973B1 (de) 2004-07-14
CN1149086C (zh) 2004-05-12
JP4456269B2 (ja) 2010-04-28

Similar Documents

Publication Publication Date Title
FI9630U1 (fi) Järjestelmä potilaan silmän verkkokalvon hoitamiseksi laserilla
ES2182973T3 (es) Metodo para reducir la presion intraocular enel ojo de mamifero por administracion de bloqueadors de canal de potasio.
DK1572230T3 (da) Placenta alkalisk phosphatase til at kontrollere diabetes
DE69930271D1 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
FI942499A0 (fi) Indolijohdannainen, menetelmä sen valmistamiseksi ja sen lääkekäyttö
BR0012696A (pt) Composição oftálmica
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
ES2160649T3 (es) Nuevos compuestos lactamicos y procedimientos para su preparacion.
ATE281464T1 (de) Adenosinderivate und deren verwendung
ES2109752T3 (es) Medicamento para tratamiento terapeutico y profilactico de enfermedades causadas por hiperplasia de las celulas de los musculos lisos.
DE69918671D1 (de) Optische papillarzirkulation verbesserende mittel
KR960003719A (ko) 녹내장 치료제 및 안압 강하제
FI964303A (fi) Keuhkosydänvian hoitamiseen tarkoitettu aine
RU2004129767A (ru) Хинолиновые производные
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
DE69620573D1 (de) Mittel zur verminderung des augeninnendrucks
IT1313583B1 (it) Derivati 2-amminotetralinici per la terapia del glaucoma.
PT985414E (pt) Metodo de tratamento de glaucoma e retinopatia isquemica
NO20013480D0 (no) Legemiddel for törr hud
DE69829227D1 (de) Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom
Mittag et al. Alpha-adrenergic agonists and aqueous humor dynamics
Bito Ocular hypotensive effects of prostaglandins (PGs) and their analogs
Sugrue Preclinical pharmacology of topical ocular hypotensive carbonic anhydrase inhibitors
IT1274040B (it) Composizioni farmaceutiche per la prevenzione e/o il trattamento di disturbi gastrointestinali inclusa l'ulcera
TH19132A (th) วิธีการทำให้บริเวณผิวหนังของสัตว์เลี้ยงลูกด้วยนมที่มีสารสีมากเกิดไปจางลง

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: N.V. ORGANON, OSS, NL

8339 Ceased/non-payment of the annual fee